SCHEMBL7484135

SCHEMBL7484135

Cc1ccc(S(=O)(=O)Oc2nc(C)nc(OS(=O)(=O)c3ccc(C)cc3)c2[N+](=O)[O-])cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.51
NFE2L2 Q16236 1/20 0.51
MAPT P10636 4/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
HSP90AA1 P07900 3/20 0.39
CRHBP P24387 2/20 0.39
CRHR2 Q13324 2/20 0.39
LMNA P02545 2/20 0.39
RAB9A P51151 2/20 0.38
CXCR5 P32302 1/20 0.38
APLNR P35414 1/20 0.38
CCR6 P51684 1/20 0.38
GFER P55789 1/20 0.38
GPR17 Q13304 1/20 0.38
ACHE P22303 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17585445 0.90 MAPT (0.46) KEAP1NFE2L2MAPTALDH1A1KDM4E
SCHEMBL7628563 0.80 KEAP1 (0.40) KEAP1NFE2L2MAPTALDH1A1KDM4E
SCHEMBL7410681 0.77 KEAP1 (0.41) KEAP1NFE2L2MAPTALDH1A1KDM4E
SCHEMBL4322696 0.77 KEAP1 (0.53) KEAP1NFE2L2MAPTALDH1A1KDM4E
SCHEMBL2492570 0.74 LMNA (0.44) KEAP1NFE2L2MAPTALDH1A1KMT2A
SCHEMBL536774 0.73 KEAP1 (0.38) KEAP1NFE2L2MAPTALDH1A1KDM4E
SCHEMBL4051900 0.73 ADORA2A (0.48) KEAP1NFE2L2ALDH1A1
SCHEMBL9007689 0.72 PAX8 (0.49) KEAP1NFE2L2MAPTALDH1A1KMT2A
SCHEMBL29991810 0.71 KEAP1 (0.46) KEAP1NFE2L2MAPTALDH1A1KDM4E
SCHEMBL8620036 0.71 HSP90AA1 (0.58) KEAP1NFE2L2MAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448261-B1 CORTICOTROPIN RELEASING FACTOR ANTAGONISTS; TREATING ANXIETY, DEPRESSION, AND OTHER PSYCHIATRIC AND NEUROLOGICAL DISORDERS BRISTOL-MYERS SQUIBB PHARMA COMPANY 2002-09-10 US disclosed
EP-0935601-A4 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARM CO (US) 2002-08-07 EP disclosed
US-6107300-A CORTICOTROPIN RELEASING FACTOR ANTAGONIST; PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS (US) 2000-08-22 US disclosed
EP-0935601-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES Du Pont Pharmaceuticals Company (US) 1999-08-18 EP disclosed
WO-1997035539-A2 ARYLAMINO FUSED PYRIDINES AND PYRIMIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-02 WO disclosed